Inflammatory markers and coronary artery disease

被引：51

作者：

Fichtlscherer, S ^{[1
]}

Heeschen, C ^{[1
]}

Zeiher, AM ^{[1
]}

机构：

[1] Goethe Univ Frankfurt, Dept Cardiol, D-60590 Frankfurt, Germany

来源：

CURRENT OPINION IN PHARMACOLOGY | 2004年 / 4卷 / 02期

关键词：

D O I：

10.1016/j.coph.2004.01.002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In the past decade, the important role of inflammatory processes in the development and progression of atherosclerosis has been clearly established. Over the past two years, different circulating (inflammatory) biomarkers indicating the instability of atherosclerotic plaques have been identified. These new markers do not only serve as diagnostic tools for the identification of patients with unstable angina or acute myocardial infarction but also help us to identify high-risk patients. As a result, different markers are used clinically for risk stratification in stable coronary artery disease as well as in acute coronary syndromes.

引用

页码：124 / 131

页数：8

共 79 条

[11] Episodic activation of the coagulation system in unstable angina does not elicit an acute phase reaction [J].

Biasucci, LM ;

Liuzzo, G ;

Caligiuri, G ;

vandeGreef, W ;

Quaranta, G ;

Monaco, C ;

Rebuzzi, AG ;

Kluft, C ;

Maseri, A .

AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (01) :85-87

[12] Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina [J].

Blankenberg, S ;

Tiret, L ;

Bickel, C ;

Peetz, D ;

Cambien, F ;

Meyer, J ;

Rupprecht, HJ .

CIRCULATION, 2002, 106 (01) :24-30

[13] ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) [J].

Braunwald, E ;

Antman, EM ;

Beasley, JW ;

Califf, RM ;

Cheitlin, MD ;

Hochman, JS ;

Jones, RH ;

Kereiakes, D ;

Kupersmith, J ;

Levin, TN ;

Pepine, CJ ;

Schaeffer, JW ;

Smith, EE ;

Steward, DE ;

Theroux, P ;

Gibbons, RJ ;

Alpert, JS ;

Eagle, KA ;

Faxon, DP ;

Fuster, V ;

Gardner, TJ ;

Gregoratos, G ;

Russell, RO ;

Smith, SC .

CIRCULATION, 2000, 102 (10) :1193-1209

[14] Prognostic value of myeloperoxidase in patients with chest pain [J].

Brennan, M ;

Penn, MS ;

Van Lente, F ;

Nambi, V ;

Shishehbor, MH ;

Aviles, RJ ;

Goormastic, M ;

Pepoy, ML ;

McErlean, ES ;

Topol, EJ ;

Nissen, SE ;

Hazen, SL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) :1595-1604

[15] Widespread coronary inflammation in unstable angina [J].

Buffon, A ;

Biasucci, LM ;

Liuzzo, G ;

D'Onofrio, G ;

Crea, F ;

Maseri, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (01) :5-12

[16] Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].

Chenevard, R ;

Hürlimann, D ;

Béchir, M ;

Enseleit, F ;

Spieker, L ;

Hermann, M ;

Riesen, W ;

Gay, S ;

Gay, RE ;

Neidhart, M ;

Michel, B ;

Lüscher, TF ;

Noll, G ;

Ruschitzka, F .

CIRCULATION, 2003, 107 (03) :405-409

[17] Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation [J].

D'Agostino, RB ;

Grundy, S ;

Sullivan, LM ;

Wilson, P .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02) :180-187

[18] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].

Danesh, J ;

Whincup, P ;

Walker, M ;

Lennon, L ;

Thomson, A ;

Appleby, P ;

Gallimore, JR ;

Pepys, MB .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204

[19] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].

Danesh, J ;

Collins, R ;

Appleby, P ;

Peto, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482

[20]

DEBEER FC, 1982, BRIT HEART J, V47, P239

← 1 2 3 4 5 6 7 8 →